{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T06:17:23Z","timestamp":1787811443249,"version":"build-2784847793"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematopathol"],"DOI":"10.1007\/s12308-026-00708-3","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:52:19Z","timestamp":1780491139000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Shared clonal origin of angioimmunoblastic T-cell lymphoma and Burkitt lymphoma arising through divergent evolution from a common precursor"],"prefix":"10.1007","volume":"19","author":[{"given":"FNU","family":"Monika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hammad","family":"Tashkandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"708_CR1","volume-title":"Nodal T follicular helper cell lymphoma, angioimmunoblastic type","author":"AD Attygalle","year":"2024","unstructured":"Attygalle AD, Sewell WA, Du M-Q, Iqbal J, Sakata-Yanagimoto M, Amador C, Tournilhac O (2024) Nodal T follicular helper cell lymphoma, angioimmunoblastic type, 5th ed. International Agency for Research on Cancer, Lyon (France)","edition":"5th ed"},{"key":"708_CR2","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/cam4.2742","volume":"9","author":"AE Eladl","year":"2020","unstructured":"Eladl AE, Shimada K, Suzuki Y, Takahara T, Kato S, Kohno K, Elsayed AA, Wu CC, Tokunaga T, Kinoshita T et al (2020) EBV status has prognostic implication among young patients with angioimmunoblastic T-cell lymphoma. Cancer Med 9:678\u2013688. https:\/\/doi.org\/10.1002\/cam4.2742","journal-title":"Cancer Med"},{"key":"708_CR3","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1182\/blood-2013-10-531509","volume":"123","author":"O Odejide","year":"2014","unstructured":"Odejide O, Weigert O, Lane AA, Toscano D, Lunning MA, Kopp N, Kim S, van Bodegom D, Bolla S, Schatz JH et al (2014) A targeted mutational landscape of angioimmunoblastic T-cell lymphoma. Blood 123:1293\u20131296. https:\/\/doi.org\/10.1182\/blood-2013-10-531509","journal-title":"Blood"},{"key":"708_CR4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/ng.2872","volume":"46","author":"M Sakata-Yanagimoto","year":"2014","unstructured":"Sakata-Yanagimoto M, Enami T, Yoshida K, Shiraishi Y, Ishii R, Miyake Y, Muto H, Tsuyama N, Sato-Otsubo A, Okuno Y et al (2014) Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat Genet 46:171\u2013175. https:\/\/doi.org\/10.1038\/ng.2872","journal-title":"Nat Genet"},{"key":"708_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ccr.2011.06.003","volume":"20","author":"C Quivoron","year":"2011","unstructured":"Quivoron C, Couronn\u00e9 L, Della Valle V, Lopez CK, Plo I, Wagner-Ballon O, Do Cruzeiro M, Delhommeau F, Arnulf B, Stern MH et al (2011) TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell 20:25\u201338. https:\/\/doi.org\/10.1016\/j.ccr.2011.06.003","journal-title":"Cancer Cell"},{"key":"708_CR6","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1080\/10428194.2019.1627541","volume":"60","author":"M Tobiasson","year":"2019","unstructured":"Tobiasson M, Pandzic T, Cavelier L, Sander B, Wahlin BE (2019) Angioimmunoblastic T-cell lymphoma and myelodysplastic syndrome with mutations in TET2, DNMT3 and CUX1 - azacitidine induces only lymphoma remission. Leuk Lymphoma 60:3316\u20133319. https:\/\/doi.org\/10.1080\/10428194.2019.1627541","journal-title":"Leuk Lymphoma"},{"key":"708_CR7","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1182\/bloodadvances.2020001636","volume":"4","author":"NE Lewis","year":"2020","unstructured":"Lewis NE, Petrova-Drus K, Huet S, Epstein-Peterson ZD, Gao Q, Sigler AE, Baik J, Ozkaya N, Moskowitz AJ, Kumar A et al (2020) Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms. Blood Adv 4:2261\u20132271. https:\/\/doi.org\/10.1182\/bloodadvances.2020001636","journal-title":"Blood Adv"},{"key":"708_CR8","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.66395","author":"S Cheng","year":"2021","unstructured":"Cheng S, Zhang W, Inghirami G, Tam W (2021) Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking. Elife. https:\/\/doi.org\/10.7554\/eLife.66395","journal-title":"Elife"},{"key":"708_CR9","doi-asserted-by":"publisher","DOI":"10.1101\/mcs.a006313","author":"D Nkosi","year":"2023","unstructured":"Nkosi D, Allbee AW, Rothberg PG, Friedberg JW, Evans AG (2023) Common clonal origin of three distinct hematopoietic neoplasms in a single patient: B-cell lymphoma, T-cell lymphoma, and polycythemia vera. Cold Spring Harb Mol Case Stud. https:\/\/doi.org\/10.1101\/mcs.a006313","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"708_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bneo.2025.100112","volume":"2","author":"M Yan","year":"2025","unstructured":"Yan M, Stuver R, Lin KS, Johnson WT, Horwitz SM, Dogan A, Xiao W (2025) Temporal clonal relatedness between myeloid neoplasm and nodal T-follicular helper cell lymphoma: a retrospective study. Blood Neoplasia 2. https:\/\/doi.org\/10.1016\/j.bneo.2025.100112","journal-title":"Blood Neoplasia"},{"key":"708_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/path.4898","volume":"242","author":"FH Schwartz","year":"2017","unstructured":"Schwartz FH, Cai Q, Fellmann E, Hartmann S, M\u00e4yr\u00e4np\u00e4\u00e4 MI, Karjalainen-Lindsberg M-L, Sundstr\u00f6m C, Scholtysik R, Hansmann M-L, K\u00fcppers R (2017) TET2 mutations in B cells of patients affected by angioimmunoblastic T-cell lymphoma. J Pathol 242:129\u2013133. https:\/\/doi.org\/10.1002\/path.4898","journal-title":"J Pathol"},{"key":"708_CR12","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/j.1365-2141.2007.06725.x","volume":"138","author":"K Willenbrock","year":"2007","unstructured":"Willenbrock K, Brauninger A, Hansmann ML (2007) Frequent occurrence of B-cell lymphomas in angioimmunoblastic T-cell lymphoma and proliferation of Epstein-Barr virus-infected cells in early cases. Br J Haematol 138:733\u2013739. https:\/\/doi.org\/10.1111\/j.1365-2141.2007.06725.x","journal-title":"Br J Haematol"},{"key":"708_CR13","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1097\/PAS.0b013e31802d68e9","volume":"31","author":"AD Attygalle","year":"2007","unstructured":"Attygalle AD, Kyriakou C, Dupuis J, Grogg KL, Diss TC, Wotherspoon AC, Chuang SS, Cabecadas J, Isaacson PG, Du MQ et al (2007) Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression. Am J Surg Pathol 31:1077\u20131088. https:\/\/doi.org\/10.1097\/PAS.0b013e31802d68e9","journal-title":"Am J Surg Pathol"},{"key":"708_CR14","doi-asserted-by":"publisher","first-page":"e435","DOI":"10.1016\/S1470-2045(14)70153-6","volume":"15","author":"R Kuppers","year":"2014","unstructured":"Kuppers R, Duhrsen U, Hansmann ML (2014) Pathogenesis, diagnosis, and treatment of composite lymphomas. Lancet Oncol 15:e435-446. https:\/\/doi.org\/10.1016\/S1470-2045(14)70153-6","journal-title":"Lancet Oncol"},{"key":"708_CR15","doi-asserted-by":"publisher","first-page":"917","DOI":"10.3324\/haematol.2022.281724","volume":"108","author":"Y Liu","year":"2023","unstructured":"Liu Y, Derkach A, Lewis N, Zhu M, Zhang Y, Arcila M, Salles G, Dogan A, Xiao W (2023) Clonal hematopoiesis in diffuse large B-cell lymphoma: clinical impact and genetic relatedness to lymphoma and therapy-related myeloid neoplasm. Haematologica 108:917\u2013922. https:\/\/doi.org\/10.3324\/haematol.2022.281724","journal-title":"Haematologica"},{"key":"708_CR16","doi-asserted-by":"publisher","first-page":"E287","DOI":"10.1002\/ajh.25927","volume":"95","author":"RM Amini","year":"2020","unstructured":"Amini RM, Ljungstrom V, Abdulla M, Cavelier L, Pandzic T, Hollander P, Enblad G, Baliakas P (2020) Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome. Am J Hematol 95:E287\u2013E289. https:\/\/doi.org\/10.1002\/ajh.25927","journal-title":"Am J Hematol"},{"key":"708_CR17","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1182\/blood.2019003539","volume":"135","author":"CW Eskelund","year":"2020","unstructured":"Eskelund CW, Husby S, Favero F, Klausen TW, Rodriguez-Gonzalez FG, Kolstad A, Pedersen LB, Raty RK, Geisler CH, Jerkeman M et al (2020) Clonal hematopoiesis evolves from pretreatment clones and stabilizes after end of chemotherapy in patients with MCL. Blood 135:2000\u20132004. https:\/\/doi.org\/10.1182\/blood.2019003539","journal-title":"Blood"},{"key":"708_CR18","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.3324\/haematol.2024.286579","volume":"110","author":"R Iglesias","year":"2025","unstructured":"Iglesias R, Diaz E, Fernandez S, Miguelez M, Torres MR, Dominguez ML, Solorzano JL, Estevez M, Ona R, Bobes AM et al (2025) Clonal hematopoiesis is common in bone marrow of patients with classical Hodgkin lymphoma. Haematologica 110:2176\u20132180. https:\/\/doi.org\/10.3324\/haematol.2024.286579","journal-title":"Haematologica"},{"key":"708_CR19","doi-asserted-by":"publisher","first-page":"5949","DOI":"10.1182\/bloodadvances.2024013414","volume":"8","author":"A Vijenthira","year":"2024","unstructured":"Vijenthira A, Volpe VO, Sekar A, Santos Azevedo R, Mikhaleva M, Gibson CJ, Martindale SP, Fardoun R, Tyekucheva S, Ren Y et al (2024) Myeloid clonal hematopoiesis of indeterminate potential in patients with chronic lymphocytic leukemia. Blood Adv 8:5949\u20135956. https:\/\/doi.org\/10.1182\/bloodadvances.2024013414","journal-title":"Blood Adv"},{"key":"708_CR20","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3324\/haematol.2024.285183","volume":"110","author":"NE Lewis","year":"2025","unstructured":"Lewis NE, Petrova-Drus K, Sardana R, Huet S, Gao Q, Sethi S, Vanderbilt C, Xiao W, Roshal M, Baik J et al (2025) Polytypic b cells, monotypic\/monoclonal b-cell proliferations, and neoplastic t cells diverge from TET2-\/DNMT3A-mutant clonal hematopoiesis in follicular helper t-cell lymphomas. Haematologica 110:475\u2013480. https:\/\/doi.org\/10.3324\/haematol.2024.285183","journal-title":"Haematologica"},{"key":"708_CR21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/path.4898","volume":"242","author":"FH Schwartz","year":"2017","unstructured":"Schwartz FH, Cai Q, Fellmann E, Hartmann S, Mayranpaa MI, Karjalainen-Lindsberg ML, Sundstrom C, Scholtysik R, Hansmann ML, Kuppers R (2017) TET2 mutations in B cells of patients affected by angioimmunoblastic T-cell lymphoma. J Pathol 242:129\u2013133. https:\/\/doi.org\/10.1002\/path.4898","journal-title":"J Pathol"},{"key":"708_CR22","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2025030489","author":"L Wiegand","year":"2026","unstructured":"Wiegand L, Silva P, Noerenberg D, Christen F, Kopp K, Locher BN, Lowe P, Tilgner M, Altwasser R, Storzer V et al (2026) Clonal hematopoiesis and lymphoma-associated mutations in hematopoietic progenitors in b-cell non-Hodgkin lymphoma. Blood. https:\/\/doi.org\/10.1182\/blood.2025030489","journal-title":"Blood"},{"key":"708_CR23","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1182\/blood.2022016534","volume":"141","author":"N Thomas","year":"2023","unstructured":"Thomas N, Dreval K, Gerhard DS, Hilton LK, Abramson JS, Ambinder RF, Barta S, Bartlett NL, Bethony J, Bhatia K et al (2023) Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma. Blood 141:904\u2013916. https:\/\/doi.org\/10.1182\/blood.2022016534","journal-title":"Blood"},{"key":"708_CR24","doi-asserted-by":"publisher","first-page":"e406","DOI":"10.1016\/S2352-3026(24)00102-9","volume":"11","author":"J Dupuis","year":"2024","unstructured":"Dupuis J, Bachy E, Morschhauser F, Cartron G, Fukuhara N, Daguindau N, Casasnovas RO, Snauwaert S, Gressin R, Fox CP et al (2024) Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper t-cell lymphoma (ORACLE): an open-label randomised, phase 3 study. Lancet Haematol 11:e406\u2013e414. https:\/\/doi.org\/10.1016\/S2352-3026(24)00102-9","journal-title":"Lancet Haematol"},{"key":"708_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1410638","volume":"15","author":"L Ricard","year":"2024","unstructured":"Ricard L, Cervera P, Stocker N, Corre E, Van de Wyngaert Z, Banet A, Marjanovic Z, Dulery R, Bravetti C, Joly AC et al (2024) A combination of 5-azacytidine and nivolumab is a potentially effective rescue therapy in relapsed\/refractory AITL. Front Immunol 15. https:\/\/doi.org\/10.3389\/fimmu.2024.1410638","journal-title":"Front Immunol"}],"container-title":["Journal of Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-026-00708-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12308-026-00708-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-026-00708-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:21:25Z","timestamp":1787808085000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12308-026-00708-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["708"],"URL":"https:\/\/doi.org\/10.1007\/s12308-026-00708-3","relation":{},"ISSN":["1865-5785"],"issn-type":[{"value":"1865-5785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"21 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional Review Board (IRB) approval was not required for this single-patient case report because no identifiable Protected Health Information (PHI) was included, in accordance with our institutional policy.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The patient had previously acknowledged and consented to the institution\u2019s Notice of Privacy Practices.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Separate consent for publication was not required in accordance with our institutional policy.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"31"}}